Grifols SA Valuation
| GRFS Stock | USD 7.27 0.03 0.41% |
At this time, the firm appears to be undervalued. Grifols SA ADR retains a regular Real Value of $8.61 per share. The prevalent price of the firm is $7.27. Our model calculates the value of Grifols SA ADR from evaluating the firm fundamentals such as Return On Asset of 0.0287, current valuation of 14.37 B, and Return On Equity of 0.0271 as well as inspecting its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Grifols SA's price fluctuation is slightly risky at this time. Calculation of the real value of Grifols SA ADR is based on 3 months time horizon. Increasing Grifols SA's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Grifols stock is determined by what a typical buyer is willing to pay for full or partial control of Grifols SA ADR. Since Grifols SA is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Grifols Stock. However, Grifols SA's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 7.27 | Real 8.61 | Hype 7.36 |
The intrinsic value of Grifols SA's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Grifols SA's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Grifols SA ADR helps investors to forecast how Grifols stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Grifols SA more accurately as focusing exclusively on Grifols SA's fundamentals will not take into account other important factors: Grifols SA Total Value Analysis
Grifols SA ADR is currently forecasted to have valuation of 14.37 B with market capitalization of 7.13 B, debt of 10.12 B, and cash on hands of 549.09 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Grifols SA fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
14.37 B | 7.13 B | 10.12 B | 549.09 M |
Grifols SA Investor Information
About 58.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.89. Some equities with similar Price to Book (P/B) outperform the market in the long run. Grifols SA ADR has Price/Earnings To Growth (PEG) ratio of 0.23. The entity last dividend was issued on the 3rd of June 2021. The firm had 2:1 split on the 4th of January 2016. Based on the key measurements obtained from Grifols SA's financial statements, Grifols SA ADR is not in a good financial situation at this time. It has a very high odds of going through financial crisis in February.Grifols SA Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Grifols SA has an asset utilization ratio of 30.74 percent. This implies that the Company is making $0.31 for each dollar of assets. An increasing asset utilization means that Grifols SA ADR is more efficient with each dollar of assets it utilizes for everyday operations.Grifols SA Ownership Allocation
Grifols SA ADR has a total of 257.44 Million outstanding shares. Over half of Grifols SA's outstanding shares are owned by outside corporations. These outside corporations are typically referred to as corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Grifols SA Profitability Analysis
The company reported the previous year's revenue of 6.59 B. Net Income was 59.31 M with profit before overhead, payroll, taxes, and interest of 2.23 B.About Grifols SA Valuation
The stock valuation mechanism determines Grifols SA's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Grifols SA ADR based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Grifols SA. We calculate exposure to Grifols SA's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Grifols SA's related companies.Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company was founded in 1940 and is headquartered in Barcelona, Spain. Grifols SA operates under Drug ManufacturersGeneral classification in the United States and is traded on NASDAQ Exchange. It employs 27584 people.
Grifols SA Growth Indicators
Investing in growth stocks can be very risky. If the company such as Grifols SA does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 679.1 M | |
| Quarterly Earnings Growth Y O Y | -0.667 | |
| Forward Price Earnings | 8.1766 |
Additional Tools for Grifols Stock Analysis
When running Grifols SA's price analysis, check to measure Grifols SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Grifols SA is operating at the current time. Most of Grifols SA's value examination focuses on studying past and present price action to predict the probability of Grifols SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Grifols SA's price. Additionally, you may evaluate how the addition of Grifols SA to your portfolios can decrease your overall portfolio volatility.